Not Signed In -
Fluvastatin Extended-Release |
Lescol XL |
Clinical Trial: Efficacy and Tolerability of Fluvastatin in Adults with Dislipidemia with History of Muscle Problems
This study is currently recruiting patients.
Verified by Novartis July 2005
|
Purpose
The purpose of the study is to find a good therapy for patients who need to be treated for high cholesterol and who have difficulty tolerating other statins (such as pravastatin, simvastatin, lovastatin, atorvastatin, rosuvastatin) due to muscle pain.
| Condition | Intervention | Phase |
|---|---|---|
| Dyslipidemia | Drug: Fluvastatin | Phase IV |
MedlinePlus related topics: Metabolic Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Efficacy and Tolerability of Fluvastatin in Adults with Dislipidemia with History of Muscle Problems Due to Other Previous Statin Intake
Further Study Details:
Study start: May 2005
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria: -Dyslipidemia - History of Myalgia
Exclusion Criteria:
- Previous treatment with fluvastatin - Age < 18 years
Other protocol-defined inclusion and exclusion criteria may apply
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00125125
Novartis e-recruitment 8627788300
New Jersey
Novartis, East Hanover, New Jersey, 07936, United States; Recruiting
Novartis e-recruitment 862-778-8300
Novartis e-recruitment center, Principal Investigator
Novartis e-recruitment center, Principal Investigator
More Information
Study ID Numbers: CXUO320B2406
Last Updated: August 1, 2005
Record first received: July 29, 2005
ClinicalTrials.gov Identifier: NCT00125125
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-02
Last Updated: August 1, 2005
Record first received: July 29, 2005
ClinicalTrials.gov Identifier: NCT00125125
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-02
Resources
- Fluvastatin Extended-Release (Drug Digest)
- Lescol XL (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
